About Docetaxel Injection IP
Experience the spotlight-worthy performance of Docetaxel Injection IP 80 mg/2 ml, an elite anticancer masterpiece recognized by the Indian Pharmacopoeia. This sought-after intravenous infusion is a ready-to-use ace in cancer therapeutics, suitable for adults facing breast, prostate, gastric, and other malignancies. Precision-manufactured by reputed Indian pharmaceutical companies, its clear to pale yellow solution ensures both safety and efficacy. Provided in a sterile, single-use glass vial, this prescription-only formulation offers reliable storage, outstanding shelf stability, and high demand among healthcare professionals for robust anti-neoplastic therapy.
Surface of Application and Distinguished Features
Docetaxel Injection IP acts as a potent anticancer agent primarily on solid tumor surfaces in breast, prostate, gastric, lung, head, and neck cancers. Its application extends to both primary and metastatic conditions. Notably, the injectable solution stands out with its ready-to-use format, requiring no reconstitution, ensuring safe and swift administration. The product is presented in secure glass vials with a flip-off cap and delivers consistent dosing, making it a dependable choice for elite cancer management strategies.
Payment Terms and Delivery Estimates
Docetaxel Injection IP is readily available for distributors, exporters, suppliers, and traders throughout India. Payment terms are flexible, making transactions smooth and reliable. Orders are handled with professional care and are typically delivered via the designated FOB ports within the estimated schedule provided at purchase. Each vial is securely packed and handed over to trusted couriers for safe delivery, ensuring compliance with temperature and light protection requirements, ready for prompt medical use across the main domestic market.
FAQ's of Docetaxel Injection IP:
Q: How should Docetaxel Injection IP be administered for optimal efficacy?
A: Docetaxel Injection IP must be given as an intravenous infusion under the direct supervision of an oncologist or medical professional, with dosage and schedule tailored to individual patient conditions.
Q: What cancers is Docetaxel Injection IP indicated for?
A: This injection is indicated for adults with breast cancer, non-small cell lung cancer, prostate cancer, gastric cancer, and head and neck cancers, offering broad-spectrum antineoplastic relief.
Q: When should Docetaxel Injection IP not be used?
A: Docetaxel Injection IP is contraindicated in patients with known hypersensitivity to docetaxel or polysorbate 80, or those with critically low neutrophil counts.
Q: Where should Docetaxel Injection IP be stored before use?
A: The vials should be stored below 25C and protected from light to maintain their stability and effectiveness throughout their 24-month shelf life.
Q: What precautions should be taken during Docetaxel Injection IP therapy?
A: Routine monitoring of blood counts, liver, and renal function is necessary during therapy to manage potential side effects such as neutropenia, anemia, and fatigue.
Q: How is Docetaxel Injection IP presented and prepared for administration?
A: Each 80 mg/2 ml vial is presented in a sterile, single-use, glass vial with a flip-off cap. The solution is ready to use and does not require any reconstitution before intravenous administration.